reports
- Wim Hoste
- Wim Hoste
DSM-Firmenich Clear roadmap and strategy progress, now is the time for...
In the Investor Update, dsm-firmenich showed a detailed roadmap towards the company's mid-term targets, reflecting the anticipated step-by-step improvement. On the strategic side, dsm-firmenich will, after the announced ANH divestment, fully focus on growing its current portfolio of consumer oriented businesses. We remind that the guidance of 2026 is broadly in line with our and consensus expectations (2-4% organic sales growth and c. 20% adjusted EBITDA margin). We still appreciate dsm-firmenic...
Ontex publishes its 2025 annual report: ‘Building foundations for the ...
Ontex publishes its 2025 annual report: ‘Building foundations for the future’ Regulated information Aalst, Belgium, March 17, 2026 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care solutions, today publishes its 2025 annual report. The annual report covers Ontex’s financial, environmental, social and governance data for the year 2025, as well as its leadership and strategy. Laurent Nielly, Ontex’s CEO, said: “2025 was a challenging year for Ontex, and our performance did not meet our initial expectations. At the same time, it was a yea...
Ontex publiceert jaarverslag 2025: 'Een solide basis bouwen voor morge...
Ontex publiceert jaarverslag 2025: 'Een solide basis bouwen voor morgen’ Gereglementeerde informatie Aalst, België, 17 maart 2026 – Ontex Group NV, een toonaangevende ontwikkelaar en producent van persoonlijke verzorgingsproducten, publiceert vandaag zijn jaarverslag 2025. Het jaarverslag geeft een overzicht van de financiële, milieu-, sociale en bestuursgegevens van Ontex voor het jaar 2025, evenals informatie over het leiderschap en de strategie van het bedrijf. Laurent Nielly, CEO van Ontex: "2025 was een uitdagend jaar voor Ontex en onze resultaten voldeden niet aan onze oorspron...
Weekly progress on share repurchase program to cover share plans and r...
Weekly progress on share repurchase program to cover share plans and reduce capital Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), March 17, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 9, 2026 its intention to repurchase ordinary shares with an aggregate market value of €500 million and reduce its issued capital. On March 12, 2026, the company commenced repurchasing ordinary shares for a total amount of €540 million, of which €40 million to co...
- ING Helpdesk
- Guy Sips
- Hilde Van Boxstael
- Livio Luyten
- Lynn Hautekeete
- Michiel Declercq
- Wim Hoste
- Wim Lewi
- Wim Hoste
DSM-Firmenich Feedback from the Investor Event
In the Investor Update, dsm-firmenich showed a detailed roadmap towards the company's mid-term targets, reflecting the anticipated step-by-step improvement. On the strategic side, dsm-firmenich will, after the announced ANH divestment, fully focus on growing its current portfolio of consumer oriented businesses. We remind that the guidance of 2026 is broadly in line with our and consensus expectations (2-4% organic sales growth and c. 20% adjusted EBITDA margin). We still appreciate dsm-firmenic...
- ING Helpdesk
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Lynn Hautekeete
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
- Wim Hoste
DSM-Firmenich FIRST LOOK Investor Update: no surprise on guidance & mi...
Following the recent divestment announcement of ANH, dsm-firmenich presents is updated strategy & targets in an Investor Update which will take place in London today. After the ANH divestment, dsm-firmenich will focus on its consumer oriented businesses. As previously hinted at, Dsm-firmenich reiterated the mid term financial targets for organic sales growth and adjusted EBITDA margin whilst it has upped the cash conversion target from =10% to =14%. The guidance of 2026 is a bit more cautious th...
dsm-firmenich announces share repurchase program to cover share plans ...
dsm-firmenich announces share repurchase program to cover share plans and reduce capital Press Release dsm-firmenich announces share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), March 12, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, today starts a new program to repurchase ordinary shares for a total amount of €540 million, of which €500 million to reduce its issued capital, and €40 million to cover commitments under the Group’s share-based compensation plans. This follows the earlier announcement on ...
dsm-firmenich outlines action plan at Investor Event to accelerate per...
dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation Press Release dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation Kaiseraugst (Switzerland), Maastricht (Netherlands), March 12, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, is today holding an Investor Event in London for institutional analysts and investors from 9:30am until 1:30pm GMT. The event will be broadcast live via . Dimitri de Vreeze, Chief Executive Officer, commented: “Ov...
Transparency Declaration Notification
Transparency Declaration Notification Regulatory information In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notifications of significant shareholding by the Goldman Sachs Group, Inc., that it has received on March 3 and 4, 2026. On March 3, 2026, the Company received a transparency declaration confirming that, on February 26, 2025, the Goldman Sachs Group, Inc., detained 358,662 Ontex voting rights and 2,463,332 equivalent financial instruments or...
Kennisgeving transparantieverklaring
Kennisgeving transparantieverklaring Gereglementeerde informatie In overeenstemming met de vereisten van artikel 14 van de Belgische wet van 2 mei 2007 over de openbaarmaking van belangrijke deelnemingen in emittenten, maakt Ontex Group NV (“Ontex”) de verklaringen van belangrijke deelnemingen door Goldman Sachs Group, Inc., bekend, die op 3 en 4 maart 2026 werden ontvangen. Op 3 maart 2026 ontving de Vennootschap een transparantieverklaring waarin werd bevestigd dat Goldman Sachs Group Inc. op 26 februari 2026 358.662 stemrechten van Ontex bezat en 2.821.994 equivalente financiële in...
- ING Helpdesk
Benelux Morning Notes
Aedifica and Cofinimmo: Aedifica acquires c.80% of the shares in Cofinimmo. ASM International: 4Q25 results; strong FY26 guidance. D'Ieteren: Bloomberg reports on Belron IPO, valuation above $30bn, close to $40bn. dsm-firmenich: Symrise 2025 results and guidance. Kinepolis: Feb reassures - US box office revenue up +1% YoY, France visitors up +25% YoY. KPN: Odido data breach
dsm-firmenich cancels its shares following completion of its €1.08 bil...
dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Press Release dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), February 26 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announces that following the completion of its €1.08 billion share buyback program in 2025, the company has cancelled 12,049,441 shares. As a result, the total number of issued shares has been reduced by approximately 4.5%, from 265,676,388 to 253,62...
- Maxime Stranart
- Reg Watson
- CFA
Ontex/Another challenging year ahead/HOLD
We reiterate our HOLD rating on Ontex and lower our target price from €5.40 to €4.70, following the group's weaker-than-expected FY25 results and a FY26 guidance we see as challenging, especially given the strong headwinds the company will have to cope with over 1H26. Ontex's material exposure to the Baby care segment remains the most challenged one in our view, given unsupportive demographics trends in key markets and material price and promotion pressure from branded players. At €4.7, Ontex wo...
dsm-firmenich publishes 2025 Integrated Annual Report
dsm-firmenich publishes 2025 Integrated Annual Report Press Release dsm-firmenich publishes 2025 Integrated Annual Report Kaiseraugst (Switzerland), Maastricht (Netherlands), February 20, 2026 dsm-firmenich today announces the publication of its Integrated Annual Report (IAR) for 2025, a year during which the company advanced its innovation-led growth agenda, sharpened its strategic profile, and delivered a good performance. The 2025 IAR offers a comprehensive overview of dsm-firmenich’s financial and non-financial progress during the past year. It details the Group’s performance, inclu...
EcoVadis Gold rating validates Ontex’s business sustainability commitm...
EcoVadis Gold rating validates Ontex’s business sustainability commitments and performance for second year in a row Aalst, Belgium, February 19, 2026 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care solutions, announces that it has been awarded a Gold rating by EcoVadis for the second consecutive year. EcoVadis, a global leader in business sustainability assessments, awarded Ontex a higher total score year on year, placing the company in the top 3% of companies assessed globally. The recognition reflects the solid foundations Ontex has bu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.